194 related articles for article (PubMed ID: 34337094)
21. Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort Study.
Jorgensen SCJ; Zasowski EJ; Trinh TD; Lagnf AM; Bhatia S; Sabagha N; Abdul-Mutakabbir JC; Alosaimy S; Mynatt RP; Davis SL; Rybak MJ
Clin Infect Dis; 2020 Jun; 71(1):1-10. PubMed ID: 31404468
[TBL] [Abstract][Full Text] [Related]
22. Ceftaroline Plus Daptomycin for Refractory Methicillin- Resistant Staphylococcus aureus Bacteremia in a Child.
Hall AM; McTigue SM
J Pediatr Pharmacol Ther; 2018; 23(6):490-493. PubMed ID: 30697136
[TBL] [Abstract][Full Text] [Related]
23. Combination Therapy With Vancomycin and Ceftaroline for Refractory Methicillin-resistant Staphylococcus aureus Bacteremia: A Case Series.
Gritsenko D; Fedorenko M; Ruhe JJ; Altshuler J
Clin Ther; 2017 Jan; 39(1):212-218. PubMed ID: 28038791
[TBL] [Abstract][Full Text] [Related]
24. An Update on Treatment Options for Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: A Systematic Review.
Mahjabeen F; Saha U; Mostafa MN; Siddique F; Ahsan E; Fathma S; Tasnim A; Rahman T; Faruq R; Sakibuzzaman M; Dilnaz F; Ashraf A
Cureus; 2022 Nov; 14(11):e31486. PubMed ID: 36523711
[TBL] [Abstract][Full Text] [Related]
25. A combination of ceftaroline and daptomycin has synergistic and bactericidal activity in vitro against daptomycin nonsusceptible methicillin-resistant Staphylococcus aureus (MRSA).
Shafiq I; Bulman ZP; Spitznogle SL; Osorio JE; Reilly IS; Lesse AJ; Parameswaran GI; Mergenhagen KA; Tsuji BT
Infect Dis (Lond); 2017 May; 49(5):410-416. PubMed ID: 28116950
[TBL] [Abstract][Full Text] [Related]
26. Association of Higher Daptomycin Dose (7 mg/kg or Greater) with Improved Survival in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia.
Timbrook TT; Caffrey AR; Luther MK; Lopes V; LaPlante KL
Pharmacotherapy; 2018 Feb; 38(2):189-196. PubMed ID: 29235661
[TBL] [Abstract][Full Text] [Related]
27. Implementation of an antimicrobial stewardship pathway with daptomycin for optimal treatment of methicillin-resistant Staphylococcus aureus bacteremia.
Kullar R; Davis SL; Kaye KS; Levine DP; Pogue JM; Rybak MJ
Pharmacotherapy; 2013 Jan; 33(1):3-10. PubMed ID: 23307539
[TBL] [Abstract][Full Text] [Related]
28. Successful Clearance of Persistent Methicillin-Resistant
Shaddix G; Patel K; Simmons M; Burner K
Case Rep Infect Dis; 2019; 2019():5623978. PubMed ID: 31281689
[No Abstract] [Full Text] [Related]
29. Daptomycin and ceftaroline combination for the treatment of persistent methicillin-resistant
Alsowaida YS; Alsolami A; Almangour TA
J Chemother; 2024 Apr; ():1-6. PubMed ID: 38606836
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
Usery JB; Vo NH; Finch CK; Cleveland KO; Gelfand MS; Self TH
Am J Med Sci; 2015 Jan; 349(1):36-41. PubMed ID: 25233042
[TBL] [Abstract][Full Text] [Related]
31. Bacteremia due to Methicillin-Resistant Staphylococcus aureus: New Therapeutic Approaches.
Holubar M; Meng L; Deresinski S
Infect Dis Clin North Am; 2016 Jun; 30(2):491-507. PubMed ID: 27208769
[TBL] [Abstract][Full Text] [Related]
32. Ceftaroline and Daptomycin Combination Antibiotic Therapy for a Methicillin-Resistant
Heger ML; Al-Sayyad B
J Pediatr Pharmacol Ther; 2022; 27(8):754-759. PubMed ID: 36989005
[No Abstract] [Full Text] [Related]
33. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
Claeys KC; Zasowski EJ; Casapao AM; Lagnf AM; Nagel JL; Nguyen CT; Hallesy JA; Compton MT; Kaye KS; Levine DP; Davis SL; Rybak MJ
Antimicrob Agents Chemother; 2016 Oct; 60(10):5841-8. PubMed ID: 27431221
[TBL] [Abstract][Full Text] [Related]
34. Combination of Vancomycin or Daptomycin and Beta-lactam Antibiotics: A Meta-analysis.
Kale-Pradhan PB; Giuliano C; Jongekrijg A; Rybak MJ
Pharmacotherapy; 2020 Jul; 40(7):648-658. PubMed ID: 32533859
[TBL] [Abstract][Full Text] [Related]
35. A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations - results of a prematurely terminated study.
Kalimuddin S; Chan YFZ; Phillips R; Ong SP; Archuleta S; Lye DC; Tan TT; Low JGH
Trials; 2018 Jun; 19(1):305. PubMed ID: 29859132
[TBL] [Abstract][Full Text] [Related]
36. Daptomycin in combination with other antibiotics for the treatment of complicated methicillin-resistant Staphylococcus aureus bacteremia.
Dhand A; Sakoulas G
Clin Ther; 2014 Oct; 36(10):1303-16. PubMed ID: 25444563
[TBL] [Abstract][Full Text] [Related]
37. Comparative-effectiveness of ceftaroline and daptomycin as first-line MRSA therapy for patients with sepsis admitted to hospitals in the United States Veterans Health Care System.
Mootz ML; Britt RS; Mootz AA; Lee GC; Reveles KR; Evoy KE; Teng C; Frei CR
Hosp Pract (1995); 2019 Oct; 47(4):186-191. PubMed ID: 31578888
[No Abstract] [Full Text] [Related]
38. Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches.
Holubar M; Meng L; Alegria W; Deresinski S
Infect Dis Clin North Am; 2020 Dec; 34(4):849-861. PubMed ID: 33011050
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of ceftaroline, vancomycin, daptomycin, or ceftaroline plus daptomycin against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations.
Werth BJ; Barber KE; Ireland CE; Rybak MJ
Antimicrob Agents Chemother; 2014 Jun; 58(6):3177-81. PubMed ID: 24663016
[TBL] [Abstract][Full Text] [Related]
40. Ceftaroline as Salvage Monotherapy for Persistent MRSA Bacteremia.
Burnett YJ; Echevarria K; Traugott KA
Ann Pharmacother; 2016 Dec; 50(12):1051-1059. PubMed ID: 27520326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
